Homepage
PR Newswire
31-10-2014, 03:53 PM
@specuvestor
technically on the b/s side, it is still the same, just switching from AFS investment to associate. It is sort of ambiguous on the treatment part since ~14% stake as AFS investment is carried at MTM then when you rebook it (+6% to 20% stake) as an associate, the 6% will be at the acquired cost (which is also the MTM value). Also it's just recycling of PnL as the equity base is unchanged.
technically on the b/s side, it is still the same, just switching from AFS investment to associate. It is sort of ambiguous on the treatment part since ~14% stake as AFS investment is carried at MTM then when you rebook it (+6% to 20% stake) as an associate, the 6% will be at the acquired cost (which is also the MTM value). Also it's just recycling of PnL as the equity base is unchanged.